🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being

Recruitingn/aAges 18 Years - anyAllImperial College London
NCT06885905 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. All patients \>/= 18 years old and able to provide informed consent 2. Patients with a diagnosis of chronic pulmonary aspergillosis 3. To speak and understand English 4. Able to provide informed consent
💊

What it tests

  • Not listed
📍

Where

3 sites
Ninewells Hospital & Medical School
Dundee, United Kingdom
Imperial College London
London, United Kingdom
Manchester NHS Foundation Trust
Manchester, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy